Loading...
*  Imipraminoxide
Lingjaerde O (November 1971). "[Imiprex "Dumex" (imipramine oxide). A new tricyclic antidepressive agent]". Tidsskrift for Den ... preliminary investigation of a new antidepressive drug". The American Journal of Psychiatry. 120: 277-8. PMID 13944543. ...
*  Sertraline
"Sertraline versus other antidepressive agents for depression". The Cochrane Database of Systematic Reviews (4): CD006117. doi: ... McMahon CG, Porst H (October 2011). "Oral agents for the treatment of premature ejaculation: review of efficacy and safety in ... While imprecise, comparison of the results of trials of sertraline with separate trials of other anti-panic agents ( ... Central Nervous System Agents in Medicinal Chemistry. 9 (Sept): 197-204. doi:10.2174/1871524910909030197. PMID 20021354. ...
*  Mirtazapine
"Mirtazapine versus other antidepressive agents for depression". The Cochrane Database of Systematic Reviews (12): CD006528. doi ... I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer ... "Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents". J. Med. Chem. 48 (6 ...
*  Somnolence
"Mirtazapine versus other antidepressive agents for depression". Cochrane Database of Systematic Reviews (12): CD006528. doi: ... other agents impacting the central nervous system in sufficient or toxic doses A number of diagnostic tests, including the ... bacterial or other agents) encephalopathy - (hepatic, uremic or other causes) epilepsy - after seizure fibromyalgia ...
*  Milnacipran
"Milnacipran versus other antidepressive agents for depression". Cochrane Database of Systematic Reviews. 8 (3): CD006529. doi: ... acceptability and tolerability when comparing milnacipran with other antidepressant agents. However, compared with TCAs, ...
*  Nomifensine
Galbaud du Fort, G. (1988). "Hematologic toxicity of antidepressive agents" [Hematologic Toxicity of Antidepressive Agents]. ... Hoffmann, I; Ehrhart, G; Schmitt, K (1971). "8-amino-4-phenyl-1,2,3,4-tetrahydroisoquinolines, a new group of antidepressive ...
*  Tricyclic antidepressant
Tricyclic Antidepressive Agents at the US National Library of Medicine Medical Subject Headings (MeSH). ... having been replaced by more effective agents with fewer side effects such as atomoxetine (Strattera, Tomoxetin, Attentin) and ...
*  Fluvoxamine
"Fluvoxamine versus other anti-depressive agents for depression". Cochrane Database of Systematic Reviews (9): CD006114. doi: ... Central Nervous System Agents in Medicinal Chemistry. 9 (3): 197-204. doi:10.2174/1871524910909030197. PMID 20021354. Sittig's ...
*  Escitalopram
"Citalopram versus other anti-depressive agents for depression". Cochrane Database Syst Rev. 7: CD006534. doi:10.1002/14651858. ...
*  Second-generation antidepressant
Second-Generation Antidepressive Agents at the US National Library of Medicine Medical Subject Headings (MeSH) Diagrams at ...
*  Lortalamine
... a new antidepressive agent, in rats and dogs". Drug Metabolism and Disposition: the Biological Fate of Chemicals. 9 (3): 233-9 ... Norepinephrine reuptake inhibitor David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0 ...
*  List of MeSH codes (D16)
... antidepressive agents MeSH D27.505.954.427.700.122.050 --- antidepressive agents, second-generation MeSH D27.505.954.427. ... anti-allergic agents MeSH D27.505.954.122 --- anti-infective agents MeSH D27.505.954.122.085 --- anti-bacterial agents MeSH ... antiviral agents MeSH D27.505.954.122.388.077 --- anti-retroviral agents MeSH D27.505.954.122.388.077.088 --- anti-hiv agents ... renal agents MeSH D27.505.954.613.056 --- anti-infective agents, urinary MeSH D27.505.954.613.860 --- uricosuric agents MeSH ...
*  Octamoxin
"Dictionary of pharmacological agents - Google Books". "13-06781. Octamoxin [Archived]: The Merck Index". Levy J, Michel-Ber E ( ... 1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of ...
*  Tandamine
... a potential antidepressive drug". Psychopharmacology. 52 (1): 73-7. doi:10.1007/BF00426603. PMID 403562. Pugsley TA, Lippmann W ... a new potential antidepressant agent, on biogenic amine uptake mechanisms and related activities". Biochemical Pharmacology. 25 ...
*  Indeloxazine
Hayes AG, Chang T (January 1983). "Determination of indeloxazine, a new antidepressant agent, in human plasma by gas-liquid ... and its derivatives with potential cerebral-activating and antidepressive properties". Chemical & Pharmaceutical Bulletin. 33 ( ... ISBN 978-3-88763-075-1. r Ganellin, C; j Triggle, D; MacDonald, F. (1997). Dictionary of pharmacological agents - Google Books ... Indeloxazine acts as a serotonin releasing agent, norepinephrine reuptake inhibitor, and NMDA receptor antagonist. It has been ...
*  Phosphodiesterase inhibitor
PDE4 inhibitors may have antidepressive effects and have also recently been proposed for use as antipsychotics. On October 26, ... The potential for selective phosphodiesterase inhibitors as therapeutic agents was predicted as early as 1977 by Weiss and Hait ... Recent studies have shown Quinazoline type PDE7 inhibitor to be potent anti-inflammatory and neuroprotective agents. Papaverine ... Weiss B.; Hait W.N. (1977). "Selective cyclic nucleotide phosphodiesterase inhibitors as potential therapeutic agents". Annu. ...
*  Serotonin-norepinephrine reuptake inhibitor
Selectivity of antidepressant agents are based on the neurotransmitters that are thought to influence symptoms of depression. ... Venlafaxine was the first compound described in a new class of antidepressive substances called phenylethylamines. These ... Agents with dual serotonin and norepinephrine reuptake inhibition (SNRIs) are sometimes called non-tricyclic serotonin and ... A closely related type of drug is a serotonin-norepinephrine releasing agent (SNRA), for instance the withdrawn appetite ...
*  Opiorphin
Thanawala V, Kadam VJ, Ghosh R (October 2008). "Enkephalinase inhibitors: potential agents for the management of pain". Curr ... In addition, opiorphin may exert anti-depressive and antipanic action. Therapeutic application of opiorphin in humans would ...
*  Buprenorphine
The usual reversal agents for opioids, such as naloxone, may be only partially effective and additional efforts to support ... Emrich HM, Vogt P, Herz A (1982). "Possible antidepressive effects of opioids: Action of buprenorphine". Annals of the New York ... Nyhuis PW, Specka M, Gastpar M (2006). "Does the antidepressive response to opiate treatment describe a subtype of depression ... Possible therapeutic applications as animal models show antidepressive, anxiolytic, stress relieving, and anti-addictive ...
*  Bifemelane
David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. p. 265. ISBN 0-412-46630-9. ... Moryl E, Danysz W, Quack G (June 1993). "Potential antidepressive properties of amantadine, memantine and bifemelane". ...
*  Antidepressant
Further agents (hypericum, rMAO-As, SNRI, NRI, NaSSAs, SARI) showed some positive results, but limitations of the currently ... It is unknown if undergoing psychological therapy at the same time as taking anti-depressants enhances the anti-depressive ... These include lithium and thyroid augmentation, dopamine agonists, sex steroids, NRIs, glucocorticoid-specific agents, or the ... From a 2500-year-old apotropic comes a current antidepressive. The cultural history and mistique of St. John's wort]. Pharmazie ...
*  Tranylcypromine
August 2012). "Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic ... Compared to amphetamine, tranylcypromine shows low potency as a dopamine releasing agent, with even weaker potency for ... It is used as an antidepressant and anxiolytic agent in the clinical treatment of mood and anxiety disorders, respectively. ... alternative agents are recommended. Other studies have come to similar conclusions. Pharmacokinetic interactions with ...
*  Management of depression
Response rates to the first agent administered may be as low as 50%. It may take anywhere from three to eight weeks after the ... The Characteristics of an Exercise Program that will Maximize the Anti-depressive Properties Goyal M, Singh S, Sibinga EM, ... They are still used only rarely, although newer agents of this class (RIMA), with a better side effect profile, have been ... with medication offered only in conjunction with the former and generally not as a first line agent. The possibility of ...
*  Trimipramine
ISBN 978-0-915274-23-9. I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties ... Berger M, Gastpar M (1996). "Trimipramine: a challenge to current concepts on antidepressives". Eur Arch Psychiatry Clin ... Trimipramine should not be given with sympathomimetic agents such as epinephrine (adrenaline), ephedrine, isoprenaline, ...
*  Neurobiological effects of physical exercise
Brené S, Bjørnebekk A, Aberg E, Mathé AA, Olson L, Werme M (2007). "Running is rewarding and antidepressive". Physiol. Behav. ... The clinical actions of fluoxetine, like those of many neuropharmacologic agents, reflect drug-induced neural plasticity, which ... The Characteristics of an Exercise Program that will Maximize the Anti-depressive Properties Den Heijer AE, Groen Y, Tucha L, ...